Comparison of adverse events following injection of original or generic docetaxel for the treatment of breast cancer-Reference-Cited by-同舟云学术

Comparison of adverse events following injection of original or generic docetaxel for the treatment of breast cancer

Published:2017-09-01 Issue:4 Volume:80 Page:841-849
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Tagawa Nao^ORCID,Sugiyama Erika,Tajima Masataka,Sasaki Yasutsuna,Nakamura Seigo,Okuyama Hiromi,Shimizu Hisanori,Sato Vilasinee Hirunpanich,Sasaki Tadanori,Sato Hitoshi

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/article/10.1007/s00280-017-3425-3/fulltext.html

Reference28 articles.

1. Ministry of Health, Labor and Welfare (2012) Guideline for Bioequivalence Studies of Generic. Ministry of Health, Labor and Welfare Web. http://www.nihs.go.jp/drug/be-guide(e)/Generic/GL-E_120229_BE.pdf . Accessed 10 Aug 2017

2. Cortes JE, Pazdur R (1995) Docetaxel. J Clin Oncol 13(10):2643–2655

3. Iusuf D, Hendrikx JJ, van Esch A, Wagenaar E, Rosing H, Beijnen JH, Schinkel AH (2015) Human OATP1B1, OATP1B3 and OATP1A2 can mediate the in vivo uptake and clearance of docetaxel. Int J Cancer 136(1):225–233

4. Royer I, Monsarrat B, Sonnier M, Wright M, Cresteil T (1996) Metabolism of docetaxel by human Cytochromes P450: interactions with paclitaxel and other antineoplastic drugs. Cancer Res 56(1):58–65

5. de Graan AJ, Lancaster CS, Obaidat A, Hagenbuch B, Elens L, Friberg LE, de Bruijn P, Hu S, Gibson AA, Bruun GH, Corydon TJ, Mikkelsen TS, Walker AL, Du G, Loos WJ, van Schaik RH, Baker SD, Mathijssen RH, Sparreboom A (2012) Influence of polymorphic OATP1B-type carriers on the disposition of docetaxel. Clin Cancer Res 18(16):4433–4440

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of oral mucositis induced by anthracycline-cyclophosphamide and subsequent docetaxel treatment for perioperative breast cancer;Supportive Care in Cancer;2024-07-13

2. S-(N,N-diethyldithiocarbamoyl)-N-acetyl- l -cysteine for the treatment of non-small cell lung cancer through regulating NF-κB signalling pathway without neurotoxicity;Journal of Drug Targeting;2024-07-12

3. Suppression of N-Glycosylation of Zinc Finger Protein 471 Affects Proliferation, Invasion, and Docetaxel Sensitivity of Tongue Squamous Cell Carcinoma via Regulation of c-Myc;The American Journal of Pathology;2024-06

4. Generic substitution of amlodipine is not associated with increased risk of mortality or adverse cardiovascular events: An observational cohort study;Clinical and Translational Science;2024-03-28

5. A disulfiram derivative against lung cancer via the Notch signaling pathway without neurotoxicity and hepatotoxicity;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-12-26